Added to YB: 2025-06-17
Pitch date: 2025-06-16
MYX.AX [bullish]
Mayne Pharma Group Limited
-1.36%
current return
Author Info
Company Info
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
Market Cap
AUD 422.5M
Pitch Price
AUD 5.15
Price Target
6.70 (+32%)
Dividend
N/A
Sector
Pharmaceuticals
Category
special_situation
Not another merger arb - Mayne Pharma (MYX), no outs for Cosette
MYX.AX: Cosette invoked MAC to walk from A$7.40 binding deal despite no Australian precedent for success. Claims re: 11% Q3 sales drop, TXMD litigation (A$18.7M), FDA letter (resolved) fail to quantify A$10.76M EBITDA impact. Likely seeking price cut, market pricing <40% deal odds. Fair break price ~A$4.30 (6-11x EBITDA).
Read full article (11 min)